Expression of human glandular kallikrein, hK2, in mammalian cells

Cancer Research

Volumn 56, Issue 23, 1996, Pages 5397-5402

  Kumar, Abhay ^a   Goel, Amita S ^a   Hill, Timothy M ^a   Mikolajczyk, Stephen D ^a   Millar, Lisa S ^a   Kuus Reichel, Kristine ^a   Saedi, Mohammad S ^a  

^a Hybritech Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; KALLIKREIN; PROSTATE SPECIFIC ANTIGEN; RECOMBINANT PROTEIN; TUMOR MARKER;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; ENZYME ACTIVITY; GENE EXPRESSION; KALLIKREIN KININ SYSTEM; MALE; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN PURIFICATION; SEQUENCE HOMOLOGY;

ANIMALS; BLOTTING, WESTERN; CARCINOMA; CRICETINAE; CULTURE MEDIA, CONDITIONED; DNA, COMPLEMENTARY; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SPACE; GENE EXPRESSION; HUMANS; KALLIKREINS; MALE; MESOCRICETUS; PROSTATIC NEOPLASMS; RECOMBINANT FUSION PROTEINS; TIME FACTORS; TISSUE KALLIKREINS; TUMOR CELLS, CULTURED;

EID: 0030450658     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Wingo, P. A , Tong, T and Bolden, S Cancer statistics. CA Cancer J Clin., 45 8-30, 1995.
2. Catalona, W. J., Smith, D. S., Ratliff, T. L , Dodds, K. M., Coplen, D. E , Yuan, J J., Petros, J A , and Andriole, G L Measurement of prostate specific antigen in serum as a screening test for prostate cancer. N. Engl. J Med., 324. 1156-1161, 1991.
3. Osterling, J. E Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate J. Urol., 145: 907-923, 1991
4. Labrie, F , Dupont, A., Suburu, R , Cusan, L., Tremblay, M., Gomez, J-L., and Emond, J. Serum prostate specific antigen as pre-screening test for prostate cancer. J Urol , 147: 846-852, 1992
5. McCormack, R. T , Rittenhouse, H. G., Finlay, J A., Sokoloff, R. L., Wang, T. J., Wolfert, R L , Lilja, H , and Oesterling, J E Molecular forms of prostate-specific antigen and the human kallikrein gene family a new era. Urology, 45: 729-744, 1995.
6. Schedlich, L. J , Bennetts, B., and Morris, B. J. Primary structure of a human glandular kallikrein gene. DNA, 6: 429-437, 1987.
7. Morris, B. J hGK-1. A kallikrein gene expressed in human prostate. Clin. Exp Pharmacol Physiol., 16. 345-351, 1989
8. Young, C. Y. F., Andrews, P. E , and Tindall, D. J. Expression and androgenic regulation of human prostate-specific kallikreins. J. Androl., 16: 97-99, 1995.
9. Riegman, P. H. J , Vlietstra, R. J , Suurmeijer, L., Cleutjens, C B J. M , and Trapman, J. Characterization of the human kallikrein locus. Genomics, 14: 6-11, 1992
10. Fukushima, D., Kitamura, N , and Nakanishi, S. Nucleotide sequence of cloned cDNA for human pancreatic kallikrein Biochemistry, 24 8037-8043, 1985
11. Chapdelaine, P , Paradis, G., Tremblay, R , and Dube, J. High level of expression in the prostate of a human glandular kallikrein mRNA related to prostate-specific antigen. FEBS Lett., 236. 205-208, 1988
12. Clements, J. The glandular kallikrein family of enzymes, tissue specific expression and hormonal regulation. Endocr. Rev , 10: 393-419, 1989.
13. Young, C. Y. F., Andrews, P. E., Montgomery, B. T., and Tindall, D. J Tissue specific and hormonal regulation of human prostate-specific glandular kallikrein. Biochemistry, 31. 818-824, 1992.
14. Grauer, L., Charlesworth, M. C., Saedi, M. S , Finlay, J. A., Liu, R-S., Kuus-Reichel, K., and Tindall, D. J. Identification of human glandular kallikrein hK2 from LNCaP cells. J. Androl., 17: 353-359, 1996.
15. Lilja, H. Structure, function and regulation of the enzyme activity of prostate-specific antigen World J. Urol, 11: 188-191, 1993.
16. Lilja, H A kallikrein-hke serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J. Clin. Invest., 76: 1899-1903, 1985.
17. Lilja, H , Oldbring, J., Rannevik, G , and Laurell, C-B. Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen. J. Clin. Invest , 80: 281-285, 1987
18. Lilja, H., Abrahamsson, P-A , and Lundwall, A. Semenogelin, the predominant protein in human semen. J. Biol. Chem., 264 1894-1900, 1989.
19. Christensson, A , Laurell, C-B , and Lilja, H. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur. J. Biochem., 194 755-763, 1990
20. Vihinen, M Modeling of prostate-specific antigen and human glandular kallikrein structures Biochem. Biophys. Res. Commun., 204: 1251-1256, 1994
21. Bridon, D P , and Dowell, B. L. Structural comparison of prostate-specific antigen and human glandular kallikrein using molecular modeling. Urology, 45. 801-806, 1995.
22. Lilja, H., and Lundwall, A. Molecular cloning of epididymal and seminal vesicular transcripts encoding a semenogelin related protein. Proc Natl. Acad. Sci. USA, 89: 4559-4563, 1992
23. Deperthes, D , Chapdelaine, P., Tremblay, R. R., Brunet, C , Berton, J., Hebert, J., Lazare, C., and Dube, J. Y. Isolation of prostatic kallikrein hK2, also known as hGK-1, in human seminal plasma. Biochim. Biophys. Acta, 1245: 311-316, 1995
24. Saedi, M. S , Cass, M. M J , Goel, A S , Grauer, L. S., Hogen, K. L., Okaneya, T , Griffin, B Y., Klee, G. G , Young, C. Y F , and Tindall, D. J. Overexpression of a human prostate-specific glandular kallikrein, hK2, in E. coli and generation of antibodies. Mol. Cell. Endocrinol., 109: 237-241, 1995.
25. Lovgren, J., Piironen, T., Overmo, C., Dowell, B., Karp, M., Petterson, K , Lilja, H., and Lundwall, A. Production of recombinant PSA and hK2 and analysis of their immunologic cross-reactivity. Biochem. Biophys. Res. Commun., 231: 888-895, 1995.
26. Berg, D T , McClure, D B., and Grinnell, B W E1a-responsive mammalian hot/vector system for the stable high-level expression of secreted proteins Nucleic Acids Res., 20: 5485-5486, 1992
27. Miller, A. D., and Rosman, G. J. Improved retroviral vectors for gene transfer and expression Biotechniques, 7: 980-990, 1989.
28. Yokoyama, W. M. Production of monoclonal antibodies In: J. E. Coligan, A M. Kruisbeek, D. H. Margulies, E. M. Sevach, and W. Strober (eds.), Current Protocols in Immunology, pp. 2.5.1-2.5 17, New York: John Wiley and Sons, 1991.
29. Schneider, C. Newman, R A , Sutherland, D R., Asser, U , and Greaves, M. F. A one-step purification of membrane proteins using a high efficiency immunomatrix J Biol Chem., 257: 10766-10769, 1982.
30. Fisher, J. M , and Scheller, R. H. Prohormone processing and the secretory pathways J Biol. Chem , 263: 16515-16518, 1988
31. Gierasch, L. M. Signal sequences. Biochemistry, 28: 923-930, 1989.
32. Harris, R. Processing of pro-hormone precursor proteins Arch Biochem. Biophys , 275: 315-333, 1989
33. Van Veldhuizen, P J., Sadasivan, R., Wyatt, A , and Herdler, J. The plasminogen activator system in human prostatic cancer cell lines. Proc. Am Assoc. Cancer Res , 35: 608, 1994.
34. Watt, K. W K., Lee, P-J., M'TimKulu, T., Chan, W-P., and Loor, R. Human prostate-specific antigen, structural and functional similarity with serine proteases Proc. Natl Acad. Sci. USA. 83 3166-3170, 1986.
35. Kanety, H , Madjar, Y., Dagan, Y , Levi, J., Papa, M J., Pariente, C., Goldwasser, B , and Karasik, A. Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen. J. Clin. Endocrinol. Metab., 77: 229-233, 1992.